Primary Peritoneal Carcinoma Terminated Phase 2 Trials for Tivozanib (DB11800)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01972516Tivozanib As Maintenance Therapy In GYNTreatment